Nutra Pharma Corp (NPHC) Non Operating Income (2011 - 2026)

Nutra Pharma has disclosed Non Operating Income across 13 years of filings, most recently posting -$3.5 million for Q2 2026.

• In Q2 2026, Non Operating Income fell 632.23% year-over-year to -$3.5 million; the TTM figure through Jun 2026 stood at -$3.8 million (down 623.52% YoY), while the FY2025 annual figure was -$585054.0, down 43.66% from the prior year.
• Non Operating Income came in at -$3.5 million for Q2 2026 at Nutra Pharma, down from -$80426.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $5.3 million in Q1 2022 to a low of -$3.5 million in Q2 2026.
• Average Non Operating Income over 5 years is $277326.0, with a median of -$99892.0 recorded in 2023.
• The largest YoY upside for Non Operating Income was 547.09% in 2025 against a maximum downside of 701.6% in 2025.
• Over 5 years, Non Operating Income stood at $4.3 million in 2022, then tumbled by 102.42% to -$102842.0 in 2023, then surged by 49.4% to -$52040.0 in 2024, then surged by 56.55% to -$22612.0 in 2025, then sank by 15437.36% to -$3.5 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$3.5 million in Q2 2026, -$80426.0 in Q1 2026, and -$22612.0 in Q4 2025.